Advenchen Laboratories, Llc
Clinical trials sponsored by Advenchen Laboratories, Llc, explained in plain language.
-
New hope for rare sarcoma patients: AL3818 drug trial underway
Disease control Recruiting nowThis phase 3 trial tests the drug AL3818 (anlotinib) in people with advanced alveolar soft part sarcoma, leiomyosarcoma, or synovial sarcoma. Currently, only patients with alveolar soft part sarcoma are being enrolled. Participants receive AL3818 pills or a standard chemotherapy …
Phase: PHASE3 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New combo therapy aims to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests two drugs, AL8326 and toripalimab, together in people with advanced solid tumors that have not responded to standard treatments. The goal is to find the best dose and see if the combination can shrink tumors. About 228 adults will take part in this early-phase tr…
Phase: PHASE1, PHASE2 • Sponsor: Advenchen Laboratories, LLC • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC